HUP0103017A3 - Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use - Google Patents

Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Info

Publication number
HUP0103017A3
HUP0103017A3 HU0103017A HUP0103017A HUP0103017A3 HU P0103017 A3 HUP0103017 A3 HU P0103017A3 HU 0103017 A HU0103017 A HU 0103017A HU P0103017 A HUP0103017 A HU P0103017A HU P0103017 A3 HUP0103017 A3 HU P0103017A3
Authority
HU
Hungary
Prior art keywords
impairment
treatment
pharmaceutical composition
diseases caused
cognitive functions
Prior art date
Application number
HU0103017A
Other languages
English (en)
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Priority to HU0103017A priority Critical patent/HUP0103017A3/hu
Publication of HUP0103017D0 publication Critical patent/HUP0103017D0/hu
Priority to PCT/HU2002/000069 priority patent/WO2003007926A2/en
Priority to IL15984102A priority patent/IL159841A0/xx
Priority to SK31-2004A priority patent/SK312004A3/sk
Priority to DE60228968T priority patent/DE60228968D1/de
Priority to JP2003513535A priority patent/JP2004537548A/ja
Priority to YU4904A priority patent/RS4904A/sr
Priority to KR10-2004-7000792A priority patent/KR20040017326A/ko
Priority to CZ200460A priority patent/CZ200460A3/cs
Priority to CNA028163729A priority patent/CN1545410A/zh
Priority to EP02745700A priority patent/EP1408940B1/en
Priority to UA2004021167A priority patent/UA78714C2/uk
Priority to CA002453834A priority patent/CA2453834A1/en
Priority to US10/483,808 priority patent/US20040171696A1/en
Priority to PL02365258A priority patent/PL365258A1/xx
Priority to EA200400192A priority patent/EA006897B1/ru
Priority to AT02745700T priority patent/ATE408403T1/de
Publication of HUP0103017A2 publication Critical patent/HUP0103017A2/hu
Priority to ZA200400481A priority patent/ZA200400481B/en
Publication of HUP0103017A3 publication Critical patent/HUP0103017A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0103017A 2001-07-18 2001-07-18 Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use HUP0103017A3 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
HU0103017A HUP0103017A3 (en) 2001-07-18 2001-07-18 Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
AT02745700T ATE408403T1 (de) 2001-07-18 2002-07-18 Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon
CZ200460A CZ200460A3 (cs) 2001-07-18 2002-07-18 Název neuveden
EP02745700A EP1408940B1 (en) 2001-07-18 2002-07-18 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions
SK31-2004A SK312004A3 (en) 2001-07-18 2002-07-18 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions
DE60228968T DE60228968D1 (de) 2001-07-18 2002-07-18 Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon
JP2003513535A JP2004537548A (ja) 2001-07-18 2002-07-18 認知機能の減衰及び／又は損傷を治療するための医薬組成物
YU4904A RS4904A (en) 2001-07-18 2002-07-18 Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions
KR10-2004-7000792A KR20040017326A (ko) 2001-07-18 2002-07-18 인지 기능의 저하 및/또는 손상을 치료하기 위한 약제학적조성물
PCT/HU2002/000069 WO2003007926A2 (en) 2001-07-18 2002-07-18 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions
CNA028163729A CN1545410A (zh) 2001-07-18 2002-07-18 治疗认知功能衰退和/或损伤的药物组合物
IL15984102A IL159841A0 (en) 2001-07-18 2002-07-18 Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions
UA2004021167A UA78714C2 (en) 2001-07-18 2002-07-18 Pharmaceutical composition for treating or preventing diseases involving decreasing and/or impaired cognitive functions
CA002453834A CA2453834A1 (en) 2001-07-18 2002-07-18 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions
US10/483,808 US20040171696A1 (en) 2001-07-18 2002-07-18 Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions
PL02365258A PL365258A1 (en) 2001-07-18 2002-07-18 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions
EA200400192A EA006897B1 (ru) 2001-07-18 2002-07-18 Фармацевтическая композиция для лечения заболеваний, характеризующихся снижением и/или нарушением когнитивных функций
ZA200400481A ZA200400481B (en) 2001-07-18 2004-01-22 Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0103017A HUP0103017A3 (en) 2001-07-18 2001-07-18 Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Publications (3)

Publication Number Publication Date
HUP0103017D0 HUP0103017D0 (en) 2001-10-28
HUP0103017A2 HUP0103017A2 (hu) 2003-07-28
HUP0103017A3 true HUP0103017A3 (en) 2004-05-28

Family

ID=90001562

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103017A HUP0103017A3 (en) 2001-07-18 2001-07-18 Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Country Status (18)

Country Link
US (1) US20040171696A1 (hu)
EP (1) EP1408940B1 (hu)
JP (1) JP2004537548A (hu)
KR (1) KR20040017326A (hu)
CN (1) CN1545410A (hu)
AT (1) ATE408403T1 (hu)
CA (1) CA2453834A1 (hu)
CZ (1) CZ200460A3 (hu)
DE (1) DE60228968D1 (hu)
EA (1) EA006897B1 (hu)
HU (1) HUP0103017A3 (hu)
IL (1) IL159841A0 (hu)
PL (1) PL365258A1 (hu)
RS (1) RS4904A (hu)
SK (1) SK312004A3 (hu)
UA (1) UA78714C2 (hu)
WO (1) WO2003007926A2 (hu)
ZA (1) ZA200400481B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
HUP0301906A3 (en) * 2003-06-23 2006-03-28 Egis Gyogyszergyar Nyilvanosan Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
EP1500391A1 (en) * 2003-07-24 2005-01-26 Neuro3D Therapeutic use of bicycloheptane derivatives
CZ2006628A3 (cs) * 2004-03-12 2007-01-24 Egis Gyogyszergyár Nyrt. Kombinovaná farmaceutická kompozice pro inhibici poklesu kognitivních funkcí
JP2007528891A (ja) * 2004-03-12 2007-10-18 エギシュ ヂョヂセルヂャール エンニュ・エル・テー 複合鎮痛剤医薬組成物
KR101642113B1 (ko) 2014-10-08 2016-07-25 원광대학교산학협력단 퇴행성 뇌질환을 예방, 개선 또는 치료하는 유황의 법제 방법 및 상기 방법으로 법제된 유황
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement

Also Published As

Publication number Publication date
EA006897B1 (ru) 2006-04-28
US20040171696A1 (en) 2004-09-02
RS4904A (en) 2006-10-27
UA78714C2 (en) 2007-04-25
CA2453834A1 (en) 2003-01-30
DE60228968D1 (de) 2008-10-30
CZ200460A3 (cs) 2004-05-12
WO2003007926A3 (en) 2003-09-18
EP1408940B1 (en) 2008-09-17
WO2003007926A2 (en) 2003-01-30
IL159841A0 (en) 2004-06-20
EA200400192A1 (ru) 2004-06-24
EP1408940A2 (en) 2004-04-21
HUP0103017D0 (en) 2001-10-28
KR20040017326A (ko) 2004-02-26
PL365258A1 (en) 2004-12-27
ATE408403T1 (de) 2008-10-15
SK312004A3 (en) 2004-06-08
ZA200400481B (en) 2005-01-24
CN1545410A (zh) 2004-11-10
HUP0103017A2 (hu) 2003-07-28
JP2004537548A (ja) 2004-12-16

Similar Documents

Publication Publication Date Title
HU0103558D0 (en) Pharmaceutical composition for the treatment of stroke and traumatic brain insury
EP1392292A4 (en) PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
EP1399171A4 (en) MEDICINAL HERB COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DIABETES
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2002226690A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
HUP0401392A3 (en) Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
HUP0103017A3 (en) Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
EP1581209A4 (en) NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM
ZA200400210B (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
AU2002243883A1 (en) Cholesterol-lowering agents as treatment for psychological and cognitive disorders
GB0101146D0 (en) Treatment of skin conditions
EP1440080A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATION DISORDERS INVOLVING THE 20750
EP1551456A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RENAL DISEASES
GB0212790D0 (en) Medicament for the treatment of diabetes
HUP0400020A2 (hu) Bőrbetegségek megelőzésére vagy kezelésére használható triciklusos vegyületet tartalmazó gyógyszerkészítmény
GB0222282D0 (en) Therapeutic device for the treatment of symptons caused by diseases
EP1440165A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CELL PROLIFERATION DISORDERS USING 25943
AUPR637001A0 (en) Pharmaceutical composition for the treatment of skin conditions
HU0105291D0 (en) Pharmaceutical compositions for the treatment of indigestion and related diseases

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZV, HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU

FD9A Lapse of provisional protection due to non-payment of fees